Funding the Trials Acceleration Programme (TAP) which delivers and connects patients to clinical trials
With a new blood cancer diagnosis every 27 seconds worldwide, Cure Leukaemia funds research nurses and clinical roles at blood cancer centres across the UK, providing patients with access to innovative and potentially life-saving treatments through clinical trials. By supporting these roles, Cure Leukaemia facilitates potentially life-saving advancements in blood cancer therapies nationally but also contributes to global progress and hope for those impacted by the disease worldwide.
Event Name 
Event Date 
Event Distances 